Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013140
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology progress. The institute offers services such as applied research, basic research, experimental development, education and training, and science and technology advice. It conducts research in the areas of acoustics, astronomy, automation, biophysics, botany, chemistry, electronics, environmental sciences, geographical sciences and natural resources, geology and geophysics, mathematics, mechanics, microbiology, nano science and technology, physics, psychology, semiconductors, software, systems sciences, theoretical physics, and zoology. CAS promotes strategic partnerships with first-rate research institutions, international science organizations and multinational research and development corporations. The institute has operations in Beijing, Changchun, Chengdu, Guangzhou, Kunming, Lanzhou, Nanjing, Shanghai, Shenyang, Wuhan, Xi’an, and Xinjiang. CAS is headquartered in Beijing, China.

Chinese Academy of Sciences – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Chinese Academy of Sciences, Medical Devices Deals, 2011 to YTD 2017 9
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 11
MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 12
Licensing Agreements 13
Innovent Biologics Enters into Licensing Agreement with Chinese Academy and Shanghai Institute of Organic 13
RaQualia Pharma to Enter into Licensing Agreement with Chinese Academy of Sciences and Guangzhou Great Water Tech 14
MicroConstants Enters into Licensing Agreement with Institute of Biophysics, Chinese Academy of Sciences 15
Chinese Academy of Sciences – Key Competitors 16
Chinese Academy of Sciences – Key Employees 17
Chinese Academy of Sciences – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Recent Developments 20
Government and Public Interest 20
Sep 07, 2016: Sugar Transforms a Traditional Chinese Medicine into a Cruise Missile 20
Aug 19, 2016: Chinese researchers reveal redox sensor protein role in pathogenic mycobacteria 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Key Facts 2
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chinese Academy of Sciences, Deals By Therapy Area, 2011 to YTD 2017 8
Chinese Academy of Sciences, Medical Devices Deals, 2011 to YTD 2017 9
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 11
MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 12
Innovent Biologics Enters into Licensing Agreement with Chinese Academy and Shanghai Institute of Organic 13
RaQualia Pharma to Enter into Licensing Agreement with Chinese Academy of Sciences and Guangzhou Great Water Tech 14
MicroConstants Enters into Licensing Agreement with Institute of Biophysics, Chinese Academy of Sciences 15
Chinese Academy of Sciences, Key Competitors 16
Chinese Academy of Sciences, Key Employees 17
Chinese Academy of Sciences, Subsidiaries 18
Chinese Academy of Sciences, Joint Venture 19

★海外企業調査レポート[Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Senior Plc:企業の戦略・SWOT・財務情報
    Senior Plc - Strategy, SWOT and Corporate Finance Report Summary Senior Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • PDL BioPharma Inc (PDLI):製薬・医療:M&Aディール及び事業提携情報
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • MediciNova Inc (MNOV)-製薬・医療分野:企業M&A・提携分析
    Summary MediciNova Inc (MediciNova) is a biopharmaceutical company, which focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs such as MN-001, for the treatm …
  • Air Liquide SA:企業の戦略・SWOT・財務情報
    Air Liquide SA - Strategy, SWOT and Corporate Finance Report Summary Air Liquide SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aurora Health Care Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aurora Health Care Inc (AHC) is an integrated, not-for-profit, health care system that provides inpatient and outpatient health care in the State of Wisconsin. The organization offers its healthcare services to communities throughout eastern Wisconsin, northern Illinois and the upper peninsu …
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Leonardo S.p.A.:企業のM&A・事業提携・投資動向
    Leonardo S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leonardo S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Baumot Group AG (TINC):企業の財務・戦略的SWOT分析
    Baumot Group AG (TINC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mediolanum farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a developer and supplier of pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas, which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolics. It …
  • Avnet, Inc.:戦略・SWOT・企業財務分析
    Avnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Spine Injury Solutions Inc (SPIN):企業の財務・戦略的SWOT分析
    Summary Spine Injury Solutions Inc (SPIN), formerly Spine Pain Management Inc is a medical service provider that provides medical technology and healthcare management solutions for liability spine injuries. The company provides services such as clinical management, and billing and collection of medi …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) discovers and develops therapies for the treatment of neurological disorders. It is evaluating Prasinezumab (PRX002/RG7935), a monoclonal antibody targeting alpha-synuclein protein, against Parkinson’s disease and other related synucleinopathies; and PRX004, an i …
  • Johnson Electric Holdings Limited (179):企業の財務・戦略的SWOT分析
    Johnson Electric Holdings Limited (179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • National Thermal Power Corporation Ltd:企業のM&A・事業提携・投資動向
    National Thermal Power Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Thermal Power Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Circassia Pharmaceuticals Plc (CIR):企業の財務・戦略的SWOT分析
    Circassia Pharmaceuticals Plc (CIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Torrent Power Limited:企業の戦略・SWOT・財務情報
    Torrent Power Limited - Strategy, SWOT and Corporate Finance Report Summary Torrent Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gul Ahmed Textile Mills Limited:企業の戦略・SWOT・財務分析
    Gul Ahmed Textile Mills Limited - Strategy, SWOT and Corporate Finance Report Summary Gul Ahmed Textile Mills Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆